Venus Medtech to acquire Keystone Heart for undisclosed sum

Venus Medtech Inc., a Chinese transcatheter heart valve company, has signed an agreement to acquire Keystone Heart Ltd., a medical device company that makes the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to TriGUARD 3 and establishes its presence in the US and EMEA.

“The merger is expected to close in the fourth quarter of 2018, subject to customary closing conditions.”hhmglobal.com

• 1 source
• hhmglobal.comVenus Medtech Announces Agreement to Acquire Keystone Heart, LTDYuvrajJun 17, 2020

Summarized from public sources; check the original articles before acting on it.